Recall Alert: Weight Loss Capsules Contain Dangerous, Undeclared Drugs
Lucy’s Weight Loss System has recently issued a voluntary recall for selected lots of two of its weight loss capsules as they contain drugs that were not declared to the consumer and may pose significant health risks.
The company had decided to recall lots of its Pink Bikini and Shorts on the Beach Blue and Gold Edition capsules after it was discovered that both weight loss capsules contain Sibutramine and Phenolphthalein. This was found after a sampling and testing done by the U.S. Food and Drug Administration (FDA). To date, Lucy’s Weight Loss System says it has not received reports of illnesses or severe drug reaction from the weight loss capsules affected by the recall.
Sibutramine is an appetite suppressant withdrawn from the U.S. market back in 2010 after it was found that it can significantly increase a person’s blood pressure and/or pulse rate. This can be very dangerous to patients who have a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Meanwhile, phenolphthalein is currently not approved to be marketed throughout the United States because of concerns relating to its carcinogenicity. Moreover, the said drug may also cause “potentially serious gastrointestinal disturbances.” Hence, both drugs are deemed unsafe and life-threatening, especially if taken in combination with other medications.
The recall affects Pink Bikini and Shorts on the Beach lots with the expiration date “7/30/2017.” Meanwhile, these weight loss dietary supplements are packaged in a clear bottle in blue and gold. Moreover, these supplements were sold online and also distributed nationwide.
Lucy’s Weight Loss System says it is already notifying its customers via email and making arrangements for the return of the affected weight loss supplements. Meanwhile, customers are asked to immediately stop taking the said supplements and discard them.